Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michelle Louise O'Donoghue, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Michelle O'Donoghue and Emily Lau.
Michelle O'Donoghue
Connection Strength
2.514
Emily Lau
  1. Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials. Circulation. 2021 02 16; 143(7):685-695.
    View in: PubMed
    Score: 0.921
  2. Reply: Potent P2Y12 Inhibitor Therapy for All? But What About Ethnicity? J Am Coll Cardiol. 2017 09 12; 70(11):1425-1426.
    View in: PubMed
    Score: 0.726
  3. Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials. J Am Coll Cardiol. 2017 Mar 28; 69(12):1549-1559.
    View in: PubMed
    Score: 0.703
  4. Women and Heart Attacks. Circulation. 2016 Mar 08; 133(10):e428-9.
    View in: PubMed
    Score: 0.163
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.